Magdalena Przytulinska
Abbott (United States)(US)Discovery Laboratories (United States)(US)
Publications by Year
Research Areas
DNA Repair Mechanisms, Cancer-related Molecular Pathways, Cancer therapeutics and mechanisms, Microtubule and mitosis dynamics, Synthesis and biological activity
Most-Cited Works
- → Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents(2009)108 cited
- → Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling(2008)59 cited
- → Design, Synthesis, and Biological Activity of 5,10-Dihydro-dibenzo[b,e][1,4]diazepin-11-one-Based Potent and Selective Chk-1 Inhibitors(2007)43 cited
- → Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195(2013)29 cited
- → Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors(2008)15 cited
- → Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors(2007)10 cited
- → Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability(2007)5 cited
- → Gsk-3beta with inhibitor 6-chloro-N-cyclohexyl-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine(2013)